U.S. Senators called drug pricing practices 'morally repugnant' and to...
WASHINGTON/NEW YORK - U.S. Senators called drug pricing practices “morally repugnant” and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at the start of a Senate hearing on the rising costs of prescription medicines.
In his opening statement, Ron Wyden, the Senate Finance Committee’s top Democrat tore into each company one-by-one for “profiteering and two-faced scheming.” U.S. President Donald Trump has said drugmakers are “getting away with murder,” and his administration has made bringing down prescription medicine costs for U.S. consumers a top priority.
Pharmaceutical companies have blamed high research and development costs for their prices, as well as discounts, or rebates, they must provide to pharmacy benefits managers and insurers to ensure patient access to their medicines. HHS has proposed a rule to eliminate rebates in Medicare and Medicaid, the government health insurance programs.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Drug executives grilled in Senate over high pricesChuck Grassley opened the hearing saying that Americans are “sick and tired of the blame game.”
Lire la suite »
Pharmaceutical executives on Capitol Hill answer questions on rising drug costsThe top executives from seven major drugmakers told a Senate committee Tuesday that their industry isn’t solely to blame for historically high drug prices, setting up a clash with lawmakers who insist the companies are gaming a broken system. The testimony from several drug industry CEOs is the first
Lire la suite »
Tesla is bleeding executives and it could create problems for the company, experts sayThe level of turnover Tesla has experienced in its senior ranks is unusual in the auto industry and could make recruiting more difficult.
Lire la suite »
Tesla is bleeding executives and it may create problems for the company, experts sayThe level of turnover Tesla has experienced in its senior ranks is unusual in the auto industry and could make recruiting more difficult.
Lire la suite »
These Senators Received The Biggest Checks From Pharma Companies Testifying TuesdaySeven pharma executives are expected to face tough questions about the price of their drugs Tuesday before the U.S. Senate Finance Committee. They’ll also be answering to a group that’s received hundreds of thousands of dollars in campaign contributions from their own companies’ PACs.
Lire la suite »
Jim Carrey blasts 'repugnant oaf' Donald Trump and his 'sith' supporters with new cartoonThe actor and artists slammed people supporting Trump after his 'racism, misogyny, infidelity, environmental rape, and high treason.'
Lire la suite »
Live Analysis: Drug-Company CEOs Take the Hot Seat Before CongressRising drug prices will be in the spotlight as pharmaceutical industry executives testify before the Senate Finance Committee, where lawmakers are expected to ask executives from firms such as Merck and Pfizer about their pricing practices and other issues.
Lire la suite »
U.S. top court rejects Maryland bid to revive drug price-gouging lawThe U.S. Supreme Court on Tuesday rejected Maryland's bid to revive a law a...
Lire la suite »